Found: 21
Select item for more details and to access through your institution.
Incidence of serious infection among etanercept and infliximab initiators: safety comparison between biosimilars and bio-originators with Canadian population-based data.
- Published in:
- BMC Rheumatology, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41927-024-00415-5
- By:
- Publication type:
- Article
Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.
- Published in:
- Rheumatology International, 2017, v. 37, n. 7, p. 1111, doi. 10.1007/s00296-017-3739-9
- By:
- Publication type:
- Article
A Blended Learning Program in Rheumatology for Primary Care Physicians in Canada.
- Published in:
- Journal of Interactive Instruction Development, 2005, v. 18, n. 2, p. 3
- By:
- Publication type:
- Article
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1917-8
- By:
- Publication type:
- Article
Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).
- Published in:
- Journal of Rheumatology, 2024, v. 51, n. 5, p. 479, doi. 10.3899/jrheum.2023-0716
- By:
- Publication type:
- Article
Real-World Retention and Clinical Effectiveness of Secukinumab for Psoriatic Arthritis: Results From the Canadian Spondyloarthritis Research Network.
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 5, p. 641, doi. 10.3899/jrheum.220823
- By:
- Publication type:
- Article
Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network.
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 5, p. 634, doi. 10.3899/jrheum.220824
- By:
- Publication type:
- Article
Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Development of a Canadian Core Clinical Dataset to Support High-quality Care for Canadian Patients with Rheumatoid Arthritis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effectiveness and Safety of Infliximab in Rheumatoid Arthritis: Analysis From a Canadian Multicenter Prospective Observational Registry.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 8, p. 1142, doi. 10.1002/acr.22290
- By:
- Publication type:
- Article
Evaluation of the Severity of Systemic Sclerosis by Nailfold Capillary Microscopy in 112 Patients.
- Published in:
- Angiology, 1992, v. 43, n. 3P1, p. 203, doi. 10.1177/000331979204300305
- By:
- Publication type:
- Article
Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Pharmacologic therapy of osteoarthritis.
- Published in:
- Current Rheumatology Reports, 1999, v. 1, n. 1, p. 54, doi. 10.1007/s11926-999-0026-0
- By:
- Publication type:
- Article
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the 'pan-European registry collaboration for abatacept (PANABA).
- Published in:
- Clinical Rheumatology, 2017, v. 36, n. 4, p. 773, doi. 10.1007/s10067-016-3505-5
- By:
- Publication type:
- Article
Increased incidence of liver enzymes abnormalities in patients treated with isoniazid in combination with disease modifying and/or biologic agents.
- Published in:
- Clinical Rheumatology, 2014, v. 33, n. 8, p. 1049, doi. 10.1007/s10067-014-2528-z
- By:
- Publication type:
- Article
Patient and Healthcare Professionals Preference for Brenzys vs. Enbrel Autoinjector for Rheumatoid Arthritis: A Randomized Crossover Simulated-Use Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Transdermal fentanyl improves pain control and functionality in patients with osteoarthritis: an open-label Canadian trial.
- Published in:
- Clinical Rheumatology, 2008, v. 27, n. 5, p. 587, doi. 10.1007/s10067-007-0751-6
- By:
- Publication type:
- Article
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries.
- Published in:
- Rheumatology, 2021, v. 60, n. 2, p. 820, doi. 10.1093/rheumatology/keaa393
- By:
- Publication type:
- Article
Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists.
- Published in:
- Pharmacy Practice (1886-3655), 2021, v. 19, n. 3, p. 1, doi. 10.18549/PharmPract.2021.3.2377
- By:
- Publication type:
- Article
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry.
- Published in:
- BMC Rheumatology, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1186/s41927-020-00158-z
- By:
- Publication type:
- Article
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 2, p. 240, doi. 10.1002/acr.24966
- By:
- Publication type:
- Article